Cancer Research UK announces “largest ever” development investment
December 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK
Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …
Illegal psilocybin shows promise in treatment of depression
December 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin
A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’, has been found to have substantial mental …
NICE recommends GSK’s “first-in-class” asthma drug
November 30, 2016Sales and Marketing GSK, NICE, Nucala, asthma
NICE has announced its recommendation of GSK’s “first-in-class” biologic Nucala (mepolizumab) as an extra option for the treatment of adults …
Researchers develop capsule-based haemophilia treatment tech
November 30, 2016Research and Development University of Texas, haemophilia
Researchers at the University of Texas have developed a new method for treating haemophilia B which utilises a biodegradable oral …
Teva to shut down Maltese plant, axe 210 jobs
November 30, 2016Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva
Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …
£25m flagship manufacturing & research facility for University of Nottingham
November 30, 2016Manufacturing and Production, Research and Development University of Nottingham
Earlier this month, the University of Nottingham began work on a ‘pioneering’ Advanced Manufacturing Building. The £25 million, 9,011 square-metre …
Humira biosimilar proves efficacy in Phase 3 trial
November 30, 2016Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta
US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …
MDMA trials get FDA backing for PTSD treatment
November 30, 2016Research and Development FDA, MDMA, PTSD
The FDA have given the go-ahead to Phase 3 clinical trials investigating the efficacy of MDMA (Methylenedioxymethamphetamine) for treating post-traumatic …
Actinium snatches up ex-Novartis clinical manager
November 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actinium, Novartis, appointment
Actinium Pharmaceuticals has appointed Gregory Bergonio to the position of director of Clinical Operations, where he will first guide the …
NICE recommends 4p breast cancer drug for healthy women
November 29, 2016Research and Development, Sales and Marketing NICE, anastrozole, breast cancer
NICE has published new draft guidance calling for women with a strong family history of breast cancer to be offered …
Ireena Vittal joins Cipla executive board
November 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment
Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
PrimeVigilance and PharmInvent combine to create leading, international full service pharmacovigilance, medical information and regulatory service provider
November 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
PrimeVigilance and PharmInvent are pleased to announce that they are now working together as an integrated service provider following the …
UK oral cancer rates soar 68% over two decades
November 29, 2016Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer
As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …
Personalised medicine to drive global lung cancer market to 2020
November 29, 2016Manufacturing and Production, Sales and Marketing Technavio, lung cancer, non-small cell lung cancer
According to a new report from Technavio, the global lung cancer therapeutics market is projected to grow at more than …
Wockhardt UK sterile site hit with FDA warning
November 29, 2016Manufacturing and Production FDA, Wockhardt, Wrexham
Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter …
FDA orphan drug designation doubles PhaseRx shares
November 28, 2016Manufacturing and Production, Research and Development, Sales and Marketing FDA, Orphan Drug Designation, PhaseRx
PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …
Biosimilars and Generics: A no-brainer for treatment?
November 28, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics
The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
Patheon acquires state-of-the-art manufacturing facility from Roche
November 28, 2016Manufacturing and Production Patheon, Roche, South Carolina
Patheon, a provider of drug development and delivery to the pharmaceutical and biopharma sectors, announced that it has acquired a …
Teva to market world’s first medical marijuana inhaler
November 28, 2016Research and Development, Sales and Marketing
Israel’s Teva Pharmaceutical Industries has signed an agreement with Tel Aviv-based biotech Syqe Medical for the distribution and marketing of …
Chinese investors push Kymab backing to $100 million
November 28, 2016Sales and Marketing Bill & Melina Gates Foundation, China, kymab
Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
